Your browser doesn't support javascript.
loading
Correction to: M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway.
Yin, Hang; Chen, Lin; Piao, Shiqi; Wang, Yiru; Li, Zhange; Lin, Yuan; Tang, Xueqing; Zhang, Huijuan; Zhang, Haiyang; Wang, Xiaoyuan.
Afiliação
  • Yin H; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
  • Chen L; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, PR China.
  • Piao S; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
  • Wang Y; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
  • Li Z; Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
  • Lin Y; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, PR China.
  • Tang X; Department of Pharmacology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, PR China.
  • Zhang H; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, PR China.
  • Zhang H; Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, PR China.
  • Wang X; Department of Oncology, Yuhuangding Hospital, Yantai, Shangdong Province, PR China.
Cell Death Differ ; 30(3): 856, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36216972
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cell Death Differ Ano de publicação: 2023 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cell Death Differ Ano de publicação: 2023 Tipo de documento: Article País de publicação: Reino Unido